NCT04803240View on ClinicalTrials.gov

Survey: Evaluation of Ocular Surface Disease Symptoms and Patient Satisfaction With Thealoz® Duo After 84 Days of Daily Treatment

CompletedOBSERVATIONAL
Enrollment

310

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

December 30, 2019

Study Completion Date

March 30, 2020

Conditions
Dry Eye
Interventions
DEVICE

Thealoz Duo

Non applicable

Trial Locations (1)

Unknown

University of Plymouth, Plymouth

Sponsors

Lead Sponsor

Laboratoires Thea

Collaborators (1)

Iris Pharma
All Listed Sponsors
collaborator

Iris Pharma

INDUSTRY

lead

Laboratoires Thea

INDUSTRY

NCT04803240 - Survey: Evaluation of Ocular Surface Disease Symptoms and Patient Satisfaction With Thealoz® Duo After 84 Days of Daily Treatment | Biotech Hunter | Biotech Hunter